Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sézary syndrome with variable CD30 positivity*

1. Papadavid, E.
2. Kapniari, E.
3. Pappa, V.
4. Nikolaou, V.
5. Iliakis, T.
6. Dalamaga, M.
7. Jonak, C.
8. Porkert, S.
9. Engelina, S.
10. Quaglino, P.
11. Ortiz-Romero, P.L.
12. Vico, C.
13. Cozzio, A.
14. Dimitriou, F.
15. Guiron, R.
16. Guenova, E.
17. Hodak, E.
18. Bagot, M.
19. Scarisbrick, J.